7,126 Shares in Stryker Co. (NYSE:SYK) Acquired by Crowley Wealth Management Inc.

Crowley Wealth Management Inc. bought a new stake in shares of Stryker Co. (NYSE:SYK) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 7,126 shares of the medical technology company’s stock, valued at approximately $2,566,000. Stryker comprises 2.3% of Crowley Wealth Management Inc.’s holdings, making the stock its 14th largest holding.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. FCA Corp TX grew its position in Stryker by 0.5% during the fourth quarter. FCA Corp TX now owns 14,069 shares of the medical technology company’s stock valued at $5,065,000 after buying an additional 75 shares during the period. Vanguard Group Inc. increased its stake in shares of Stryker by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 32,698,828 shares of the medical technology company’s stock worth $11,773,213,000 after purchasing an additional 252,188 shares in the last quarter. Haverford Financial Services Inc. increased its stake in shares of Stryker by 0.3% in the 4th quarter. Haverford Financial Services Inc. now owns 18,290 shares of the medical technology company’s stock worth $6,585,000 after purchasing an additional 55 shares in the last quarter. Community Bank N.A. lifted its position in Stryker by 3.4% during the fourth quarter. Community Bank N.A. now owns 6,594 shares of the medical technology company’s stock valued at $2,374,000 after purchasing an additional 215 shares in the last quarter. Finally, Stevens Capital Management LP bought a new stake in Stryker during the fourth quarter valued at about $901,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 201,392 shares of Stryker stock in a transaction that occurred on Friday, January 31st. The shares were sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the completion of the sale, the director now owns 3,642,075 shares of the company’s stock, valued at approximately $1,428,567,498. The trade was a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Allan C. Golston sold 2,458 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the transaction, the director now directly owns 14,895 shares in the company, valued at approximately $5,705,827.65. This trade represents a 14.16 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 5.90% of the company’s stock.

Stryker Trading Down 0.8 %

SYK stock opened at $371.38 on Friday. Stryker Co. has a twelve month low of $314.93 and a twelve month high of $406.19. The stock has a market capitalization of $141.71 billion, a price-to-earnings ratio of 47.86, a price-to-earnings-growth ratio of 2.93 and a beta of 0.95. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The firm’s fifty day simple moving average is $384.28 and its two-hundred day simple moving average is $374.03.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, topping analysts’ consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same period last year, the company posted $3.46 EPS. As a group, analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be paid a $0.84 dividend. The ex-dividend date is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a yield of 0.90%. Stryker’s payout ratio is 43.30%.

Analyst Ratings Changes

SYK has been the topic of several recent research reports. Barclays raised their price objective on Stryker from $418.00 to $443.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. Needham & Company LLC reiterated a “buy” rating and issued a $442.00 price target on shares of Stryker in a research report on Friday. Truist Financial raised their price objective on shares of Stryker from $409.00 to $413.00 and gave the company a “hold” rating in a research report on Thursday, January 30th. The Goldman Sachs Group set a $422.00 price target on Stryker in a research note on Tuesday, March 4th. Finally, Argus set a $450.00 price objective on Stryker in a research note on Monday, February 3rd. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $421.90.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.